Blood processing devices market seen reaching $82.01 billion by 2030

The blood processing devices and consumables market reached $51.21 billion in 2025 and is projected to climb to $82.01 billion by 2030, according to The Business Research Company. Growth is being driven by more transfusions, hospital diagnostics, infectious disease screening and demand for automated blood handling systems.

Why it matters: - Blood processing devices and consumables sit at the center of transfusions, diagnostics, apheresis and blood storage. - The market is forecast to expand from $51.21 billion in 2025 to $82.01 billion by 2030, signaling sustained demand across hospital and blood bank workflows. - Growth in safe blood handling also supports patient safety by reducing the risk of disease transmission during medical treatment.

What happened: - The Business Research Company published a market outlook on the global blood processing devices and consumables market on July 29, 2026. - The market reached $51.21 billion in 2025 and is projected to rise to $56.12 billion in 2026. - The report forecasts a 9.6% CAGR from 2025 to 2026 and a 9.9% CAGR through 2030. - The company says the market will reach $82.01 billion by 2030. - The report is available through the full report and offers a free sample.

The details: - Blood processing devices and consumables include equipment and supplies used to collect, separate, process and store blood components. - The category supports blood transfusions, therapeutic apheresis and other clinical uses of blood products. - Recent market growth has been driven by more blood transfusion procedures, more hospital-based diagnostics, more surgical interventions, stronger demand for blood component therapy and wider availability of standardized blood consumables. - Future expansion is expected to come from automated and closed-system blood processing, stricter transfusion safety measures, more therapeutic apheresis procedures, investment in blood bank modernization and wider use of digital tracking systems. - Key trends include automated blood processing technologies, high-throughput separation devices, single-use consumables, advanced blood storage options and more process standardization. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - Infectious disease pressure is a key demand driver because blood screening helps protect transfusion safety and supports diagnostics. - The report points to urbanization, globalization, climate change, increased travel and antibiotic resistance as factors spreading infectious agents and raising demand for safer blood processing. - CDC data cited in the release show U.S. tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023. - North America held the largest market share in 2025, reflecting advanced healthcare infrastructure and adoption of new medical technologies. - Asia-Pacific is expected to grow fastest over the forecast period as healthcare access, medical spending and awareness of advanced blood processing expand.

What's next: - The market is expected to keep growing as hospitals and blood banks automate more of the blood handling process. - Wider adoption of digital tracking and closed-system processing could reshape procurement and workflow standards. - The 2026 version of the report adds market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, hotspot infographics and updated graphics and tables.

The bottom line: - Blood processing devices and consumables are moving from a mature healthcare category into a higher-growth market shaped by safety, automation and expanding diagnostic demand.